Medicine

In the 1950s, people lived in fear their children might be stricken with infantile paralysis, better known as polio — and they were eager for scientists to find a solution.

The American College of Physicians says there are risks to using the anti-malarial drug on patients, and no benefit. Monitored clinical trials are advised.

The novel COVID-19 vaccine was developed in the lab of Jefferson professor Matthias Schnell, an infectious disease expert.

We look at how contact tracing works and speak to Montgomery County Commissioner Valerie Arkoosh about the high infection rates in the Pa. county.

The FDA warned health professionals last month that the drug should not be used outside of hospital or research settings, due to sometimes fatal side effects.

A Massachusetts company says its experimental vaccine against the coronavirus showed encouraging results in very early testing.

Testing more people is important, but a negative result does not necessarily mean someone is in the clear.

Health networks say they are now better prepared with COVID-19 tests and precautions, so can slowly bring patients for in-person visits and procedures.

The announcement was big news for Pa. hospitals, which has seen other states get the antiviral — the first somewhat effective coronavirus treatment.

Gilead has donated its existing supply, to be distributed by AmerisourceBergen. That company says the government decides which places can get the drug.

Would-be ER visitors are weighing their fear of worsening symptoms with their fear of exposure to the coronavirus. Doctors say that’s not a good thing.

Why one expert believes the termination of the Fox Chase Cancer Center sale is just the start of some tough times for hospitals.

Does signing a form expressing a religious objection to providing birth control to employees burden the religious freedom of employers as much as paying for the birth control?

Stephen K. Klasko, CEO of Jefferson Health, called the cancellation of the deal with Temple University “the latest casualty of COVID-19.”

A U.S. government scientist says he was ousted for resisting political pressure to allow use of a malaria drug to battle COVID-19 despite scant evidence it would work.